EATONTOWN, Apr 24, 2014 (GLOBE NEWSWIRE via COMTEX) — American CryoStem Corporation (OTCQB:CRYO), a leading biotechnology developer and licensor of patented adipose tissue-based adult stem cell technologies, today announced that its ACS Laboratory division has completed its quarterly laboratory R&D program ahead of schedule, yielding new intellectual property and positive results for expanding and differentiating adipose-derived stem cells (ADSCs). Breakthroughs in American CryoStem’s proprietary cell culture medium (ACSelerate) and culturing methodology have enabled the Company to accelerate the robust cellular expansion and rapid differentiation of ADSCs to adipocytes (fat cells), chondrocytes (cartilage-producing cells) and osteocytes (bone-producing cells).
http://bit.ly/1ihYQLH
No comments:
Post a Comment